Clinical significance of drug resistance-associated mutations in treatment of hepatitis C with direct-acting antiviral agents / 中华肝脏病杂志
Chinese Journal of Hepatology
;
(12): 170-174, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-808370
ABSTRACT
Direct-acting antiviral agents (DAAs) achieve a high sustained virologic response rate in the treatment of chronic hepatitis C virus infection. However, drug resistance-associated mutations play an important role in treatment failure and have attracted more and more attention. This article elaborates on the clinical significance of drug resistance-associated mutations from the aspects of their definition, association with genotype, known drug resistance-associated mutations and their prevalence rates, the impact of drug resistance-associated mutations on treatment naive and treatment-experienced patients, and the role of clinical detection, in order to provide a reference for clinical regimens with DAAs and help to achieve higher sustained virologic response rates.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Hepatology
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS